Global /South Korea /Healthcare /Medical Devices /246710

T&R Biofab Co., Ltd.

246710

• KRX: 246710 • Delayed

2,960KRW -3%

1.93 USD

As of 5 June 2026, T&R Biofab Co., Ltd. has a market cap of $94.38M USD, ranking #25974 globally and #1269 in South Korea. It ranks #2332 in the Healthcare sector, and #484 in the Medical Devices industry.

Global Rank

25974

Country Rank

1269

Sector Rank

2332

Industry Rank

484

Key Stats

Market Cap

$94.38MUSD

145.09B KRW

Enterprise Value

$108.81MUSD

166.79B KRW

Revenue (TTM)

$17.54MUSD

26.97B KRW

EBITDA (TTM)

-$2.37MUSD

-3.63B KRW

Net Income (TTM)

-$22.73MUSD

-34.94B KRW

EBITDA Margin

-13%

Profit Margin

-130%

PS Ratio

5.4

PB Ratio

6.3

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Devices

CEO

Wonsoo Yun open_in_new

Founded

2013

Website

tnrbiofab.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3%	-1.3%	8.7%	-14%	56%	-22%	-27%	-73%	-82%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	246710 (주)티앤알바이오팹 ISIN: KR7246710008 Shares Out.: Shares Outstanding: 47.665M¹ Shares Float: 40.123M² TV: TradingView: KRX: 246710 SA: Stock Analysis: KRX: 246710 YF: Yahoo Finance: 246710.KS GF: Google Finance: KRX: 246710 BA: Barron's: 246710 MS: Morningstar: XKRX: 246710	2,960 KRW	TV: TradingView: KRX: 246710 SA: Stock Analysis: KRX: 246710 YF: Yahoo Finance: 246710.KS GF: Google Finance: KRX: 246710 BA: Barron's: 246710 MS: Morningstar: XKRX: 246710

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About T&R Biofab Co., Ltd.

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea.

Similar Companies

Industry: Medical Devices (South Korea)

Name	Market Cap (USD) diff.	PE	Country
CLASSYS Inc. KRX: 214150	$2.44B 3.75T KRW 2K%	28.7	South Korea
SEERS Co., Ltd. KRX: 458870	$1.21B 1.86T KRW 1K%	114.8	South Korea
Livsmed Inc. KRX: 491000	$1.18B 1.81T KRW 1K%	-	South Korea
L&C BIO Co.,LTD KRX: 290650	$1.13B 1.74T KRW 1K%	-	South Korea
Seegene, Inc. KRX: 096530	$751.49M 1.16T KRW 696%	23.9	South Korea
i3system Inc. KRX: 214430	$526.7M 809.64B KRW 458%	83.3	South Korea

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 183K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 170K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 168K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 134K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 128K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 108K%	22.2	Ireland

chevron_leftBack